ERC Team Develops Heart-on-a-Chip with Integrated Sensors

Achievement date: 
2020
Outcome/accomplishment: 

The NSF-funded Nanosystems Engineering Research Center (ERC) for Cellular Metamaterials (CELL-MET), led by Boston University, has developed a versatile 3D heart-on-a-chip platform with integrated mechanical stimulators and sensors. The platform enables controlled experiments on functional cardiac tissue and a greater ability to monitor results.

Impact/benefits: 

Recreating functioning cardiac tissue for disease modeling and diagnostics requires the ability to apply stimulus in a controlled environment. The Center’s innovative platform allows both the growth and stimulation of cardiac tissue, as well as the ability to monitor tissue response on multiple levels.

Explanation/Background: 

The ERC team’s heart-on-a-chip platform enables cardiac tissue to be grown and tested in a highly controlled environment that mimics the natural habitat of heart cells. The device consists of multiple microchambers and microchannels imprinted on a layer of polymer that is sealed by bonding to another material, normally a glass slide. The chambers can be filled with cardiac microtissue and cell media for testing. Integrated mechanical stimulators and sensors allow for long-term and higher levels of monitoring.

Heart disease is the number one cause of death in the United States and a leading cause of death worldwide. This innovative technology can be used to test a number of cardiac-related therapies, including the effects of heart drugs, or methods to repair hearts damaged by disease or heart attacks.